TRI’s Biorepository Focus on Prospective Collection Services

Eric Carbonneau, Chief Operating Officer
July 5, 2023

We’ve switched more from the traditional biorepository of banked specimens to prospective specimen and consented collections services. These specimens have a richer data set and subject’s health record data associated with these biospecimens is much more valuable to researchers and scientists, as they not only have the lab results, but also relevant clinical information, such as medication history and disease states.

For example, a researcher for a particular study may need to know additional health information, such as medication or supplement use, or lifestyle history such as smoking status. Many labs do not ask for that information during sample collection or when providing other biological samples. With consenting, our research coordinators first consent the subject, obtain the needed biological samples, and then gather health and non-health-related information requested for specific research studies.

In general, freshly collected samples are more suitable for research purposes. Samples can degrade over time, even when stored frozen. By providing freshly collected samples, the Biorepository is able to provide a closer representation to the in vivo status. We do recognize there is always high demand for biological samples, and recognize that banked specimens still can provide valuable and meaningful data.

The Biorepository’s new location will include a research area dedicated to prospective collection services. Many people are interested in participating in research studies that help to advance healthcare. We respect privacy, and under appropriate circumstances, individuals who have a sample collected at a TriCore patient care center may be eligible to participate in a research study.

Learn more about TriCore Research
Institute's Biorepository

Comprehensive specimen procurement services to point you down the right path.

Insights

September 13, 2023

TriCore Research Institute: A Reliable Partner in Innovation

In the dynamic landscape of medical research and technological advancements, TriCore Research Institute (TRI) has partnered with organizations to make scientific advances in medicine Infectious Disease Research Studies The year 2020 marked a watershed moment for TriCore Research Institute (TRI). The outbreak of the SARS-CoV-2 pandemic underscored the importance of agility and continuity in research…

Read More
July 5, 2023

Right Sample, Right Test, Right Remnant: The Remnant Equation

In the ever-evolving field of clinical research, the utilization of residual clinical samples has emerged as a valuable resource. These biological samples, which are collected during routine medical procedures, hold tremendous potential for advancing scientific knowledge and improving patient care. In this blog post, we will explore the significance of residual clinical samples and their…

Read More
July 5, 2023

TRI’s Biorepository Focus on Prospective Collection Services

We’ve switched more from the traditional biorepository of banked specimens to prospective specimen and consented collections services. These specimens have a richer data set and subject’s health record data associated with these biospecimens is much more valuable to researchers and scientists, as they not only have the lab results, but also relevant clinical information, such…

Read More